| dc.creator |
NAZIROĞLU, Mustafa |
|
| dc.creator |
DOĞRU, Atalay |
|
| dc.creator |
Cig, Bilal |
|
| dc.date |
2019-09-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T11:23:01Z |
|
| dc.date.available |
2020-10-06T11:23:01Z |
|
| dc.identifier |
c64de133-044d-4cce-9c23-2031bf33f560 |
|
| dc.identifier |
10.5114/aoms.2018.79485 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/c64de133-044d-4cce-9c23-2031bf33f560/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/71647 |
|
| dc.description |
Introduction: Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory disease causing symmetric polyarthritis. In this study, we aimed to investigate the effects of infliximab (INF) and methotrexate (MTX) on apoptosis, oxidative stress, and calcium signaling in the neutrophils of RA patients. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Modulator role of infliximab and methotrexate through the transient receptor potential melastatin 2 (TRPM2) channel in neutrophils of patients with rheumatoid arthritis: a pilot study |
|
| dc.type |
info:eu-repo/semantics/article |
|